✦ LIBER ✦

RANDOMISED PHASE III TRIAL COMPARING RETROPERITONEAL LYMPH NODE DISSECTION (RPLND) WITH ONE COURSE OF BLEOMYCIN, ETOPOSIDE, CISPLATIN (BEP) CHEMOTHERAPY IN PATIENTS WITH STAGE I NON-SEMINOMATOUS GERM CELL TUMOUR PATIENTS (NSGCT) – UPDATED RESULTS OF AUO TRIAL 01/94

✍ Scribed by P. Albers; R. Siener; S. Krege; H.U. Schmelz; K.P. Dieckmann; A. Heidenreich; P. Kwasny; M. Pechoel; J. Lehmann; S. Kliesch; K.U. Köhrmann; R. Fimmers; L. Weißbach; V. Loy; C. Wittekind; M. Hartmann

Book ID: 119618394
Publisher: Elsevier Science
Year: 2008
Tongue: English
Weight: 69 KB
Volume: 7
Category: Article
ISSN: 1569-9056
DOI: 10.1016/s1569-9056(08)60057-3

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Randomized Phase III trial comparing ret

Randomized Phase III trial comparing retroperitoneal lymph node dissection with one course of bleomycin and etoposide plus cisplatin chemotherapy in the adjuvant treatment of clinical Stage I nonseminomatous testicular germ cell tumors: AUO trial AH 01/94 by the German testicular cancer study group: Albers P, Siener R, Krege S, Schmelz HU, Dieckmann KP, Heidenreich A, Kwasny P, Pechoel M, Lehmann J, Kliesch S, Köhrmann KU, Fimmers R, Weissbach L, Loy V, Wittekind C, Hartmann M, German Testicular Cancer Study Group, Department of Urology, Klinikum Kassel GmbH, Kassel, Germany

✍ Donald L. Trump 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 56 KB